MedTrace Logo

Adjunctive Oral Iron Supplementation in Atopic Dermatitis

NCT07613190 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 124

Last updated 2026-05-29

No results posted yet for this study

Summary

The present randomized controlled trial aims to evaluate the effect of adjunctive oral iron supplementation on disease severity and quality of life in adolescents with mild to moderate atopic dermatitis. In addition, the study will explore whether baseline iron status modifies treatment response and whether changes in iron biomarkers correlate with improvements in clinical severity scores.

Conditions

Interventions

DIETARY_SUPPLEMENT

Oral iron

Ferrodunal capsules providing 100 mg elemental oral iron once daily

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Principal Investigators

  • Eglal AM Bassiouny, PhD · Cairo University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
12 Years
Max Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-05-31
Primary Completion
2027-06-30
Completion
2027-10-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07613190 on ClinicalTrials.gov